Clinical Trials Browser

Has results × Astrocytoma × Everolimus × Clear all

NCT02023905 2022-12-29

Everolimus With and Without Temozolomide in Adult Low Grade Glioma

Phase 2 Terminated

27 enrolled 15 charts

Astrocytoma, Oligodendroglioma

NCT00823459 2020-07-28

Everolimus in Treating Patients With Recurrent Low-Grade Glioma

Phase 2 Completed

58 enrolled 10 charts

Astrocytoma, Brain Neoplasms, Glioma, Oligodendroglioma

NCT00553150 2020-02-13

Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma

Phase 1/2 Completed

122 enrolled 11 charts

Astrocytoma, Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

NCT00782626 2018-08-15

Everolimus (RAD001) for Children With Chemotherapy-Refractory Progressive or Recurrent Low-Grade Gliomas

Phase 2 Completed

23 enrolled 6 charts

Astrocytoma, Glioma

NCT00790400 2017-02-17

EXIST-2

Phase 3 Completed

118 enrolled 15 charts

Tuberous Sclerosis 2, Astrocytoma, Hereditary Sensory and Autonomic Neuropathies, Seizures, Tuberous Sclerosis, Lymphangioleiomyomatosis, Angiomyolipoma

NCT00789828 2016-02-03

EXIST-1

Phase 3 Completed

117 enrolled 15 charts

Astrocytoma, Tuberous Sclerosis

NCT00411619 2014-10-20

Everolimus (RAD001) Therapy of Giant Cell Astrocytoma in Patients With Tuberous Sclerosis Complex

Phase 1/2 Completed

28 enrolled 7 charts

Astrocytoma, Hereditary Sensory and Autonomic Neuropathies, Tuberous Sclerosis